Great Basin Scientific Completes Clinical Trial, Submits FDA 510(k) Application for Bordetella Direct Test
01. Februar 2017 07:00 ET
|
Great Basin Scientific, Inc.
SALT LAKE CITY, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the completion of the clinical trial and 510(k)...
Great Basin Scientific Submits 510(k) Application to the FDA for Stool Bacterial Pathogens Panel
19. Dezember 2016 07:30 ET
|
Great Basin Scientific, Inc.
SALT LAKE CITY, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today the 510(k) submission for the Stool Bacterial Pathogens...